The estimated Net Worth of Stephanie Wong is at least $107 Tysiąc dollars as of 15 April 2020. Ms. Wong owns over 5,000 units of Calithera Biosciences Inc stock worth over $1,504 and over the last 7 years she sold CALA stock worth over $105,392. In addition, she makes $0 as Vice President - Finance i Secretary at Calithera Biosciences Inc.
Stephanie has made over 4 trades of the Calithera Biosciences Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently she sold 5,000 units of CALA stock worth $40,000 on 15 April 2020.
The largest trade she's ever made was exercising 10,000 units of Calithera Biosciences Inc stock on 19 June 2019 worth over $26,400. On average, Stephanie trades about 2,039 units every 72 days since 2017. As of 15 April 2020 she still owns at least 30,082 units of Calithera Biosciences Inc stock.
You can see the complete history of Ms. Wong stock trades at the bottom of the page.
Stephanie Wong serves as Vice President - Finance, Secretary of the Company. Ms. Wong joined Calithera in April 2014 and currently serves as our Senior Vice President of Finance and Secretary. From 2009 to 2013, Ms. Wong was at SciClone Pharmaceuticals, Inc., a publicly traded, commercial-stage pharmaceutical company, most recently as Vice President, Finance and Controller. From 2008 to 2009, Ms. Wong was Senior Director, Finance at AcelRx Pharmaceuticals Inc. From 2001 to 2008, Ms. Wong held various positions at Kosan Biosciences Inc., a publicly traded biotechnology company until its acquisition by Bristol-Myers Squibb Co., most recently as Senior Director and Controller. Prior to that Ms. Wong worked as an audit manager at PricewaterhouseCoopers LLP. Ms. Wong received a B.S. in Business Administration from the University of California, Berkeley and is a Certified Public Accountant (inactive) in the State of California.
Stephanie Wong is 46, she's been the Vice President - Finance i Secretary of Calithera Biosciences Inc since 2017. There are 18 older and 2 younger executives at Calithera Biosciences Inc. The oldest executive at Calithera Biosciences Inc is H. Ward Wolff, 71, who is the Independent Director.
Stephanie's mailing address filed with the SEC is C/O CALITHERA BIOSCIENCES, INC., 343 OYSTER POINT BLVD. #200, SOUTH SAN FRANCISCO, CA, 94080.
Over the last 10 years, insiders at Calithera Biosciences Inc have traded over $23,150,153 worth of Calithera Biosciences Inc stock and bought 7,859,025 units worth $49,155,939 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Capital Partners Gp, L.L.C.... oraz Deepika Pakianathan. On average, Calithera Biosciences Inc executives and independent directors trade stock every 43 days with the average trade being worth of $8,053. The most recent stock trade was executed by Deepika Pakianathan on 27 January 2023, trading 121,333 units of CALA stock currently worth $47,320.
calithera is focused on discovering and developing first-in-class small molecule drugs that slow tumor growth through controlling key metabolic pathways in the tumor and immune cells. tumor metabolism and tumor immunology are promising new interrelated fields for cancer drug discovery. recent clinical successes have demonstrated the potential to slow abnormal cell growth and create fundamentally new therapies for cancer patients. our investigational onco-metabolism medicines take advantage of the different metabolic requirements of tumor cells and cancer-fighting immune cells. calithera’s discovery and development efforts are focused on solid tumors for which new treatments are urgently needed. we are currently developing our lead candidate in phase 2 trials in patients with renal cell carcinoma, triple negative breast cancer. targeting cancer, differently. our onco-metabolism approach brings an enhanced perspective to cancer.
Calithera Biosciences Inc executives and other stock owners filed with the SEC include: